UnitedHealth Group Incorporated (NYSE:UNH) Position Boosted by NatWest Group plc

NatWest Group plc boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 153.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,880 shares of the healthcare conglomerate’s stock after purchasing an additional 12,024 shares during the quarter. UnitedHealth Group comprises about 4.4% of NatWest Group plc’s investment portfolio, making the stock its 10th largest position. NatWest Group plc’s holdings in UnitedHealth Group were worth $10,466,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Robbins Farley bought a new position in shares of UnitedHealth Group in the third quarter worth about $25,000. CGC Financial Services LLC lifted its stake in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC lifted its position in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the last quarter. Strategic Investment Solutions Inc. IL purchased a new stake in shares of UnitedHealth Group during the first quarter valued at about $35,000. Finally, Annapolis Financial Services LLC raised its position in shares of UnitedHealth Group by 38.6% in the 3rd quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock valued at $40,000 after purchasing an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 85.69% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $490.07 on Friday. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The stock has a 50 day moving average of $504.98 and a two-hundred day moving average of $518.15. The stock has a market cap of $451.81 billion, a P/E ratio of 20.56, a P/E/G ratio of 1.33 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. The firm had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s quarterly revenue was up 14.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.34 earnings per share. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently weighed in on UNH. Royal Bank of Canada reiterated an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a report on Thursday, February 29th. HSBC restated a “reduce” rating and issued a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. Stephens reiterated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Bank of America reissued a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Finally, Barclays assumed coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 target price for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

View Our Latest Report on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.